We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lyrica Adverse Event Could Point to Withdrawal Dangers, Researchers Say
Lyrica Adverse Event Could Point to Withdrawal Dangers, Researchers Say
July 6, 2005
An elderly woman enrolled in a clinical trial of Pfizer’s antiepileptic drug Lyrica suffered a serious adverse event after abruptly discontinuing the medication — an incident that researchers say could indicate the drug poses withdrawal problems.